Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;70(2):357-369.
doi: 10.1136/gutjnl-2019-319252. Epub 2020 Mar 30.

HBV vaccination and HBV infection induces HBV-specific natural killer cell memory

Ratna S Wijaya  1   2 , Scott A Read  1   3   4 , Naomi R Truong  5 , Shuanglin Han  1 , Dishen Chen  1   3 , Haleh Shahidipour  1   3   4 , Nicole L Fewings  6 , Stephen Schibeci  6 , Mahmoud K Azardaryany  1 , Grant P Parnell  6 , David Booth  6 , David van der Poorten  7 , Rita Lin  7 , Jacob George  1   7 , Mark W Douglas  1   7   8 , Golo Ahlenstiel  9   3   4
Affiliations

HBV vaccination and HBV infection induces HBV-specific natural killer cell memory

Ratna S Wijaya et al. Gut. 2021 Feb.

Abstract

Objective: Vaccination against hepatitis B virus (HBV) confers protection from subsequent infection through immunological memory that is traditionally considered the domain of the adaptive immune system. This view has been challenged following the identification of antigen-specific memory natural killer cells (mNKs) in mice and non-human primates. While the presence of mNKs has been suggested in humans based on the expansion of NK cells following pathogen exposure, evidence regarding antigen-specificity is lacking. Here, we demonstrate the existence of HBV-specific mNKs in humans after vaccination and in chronic HBV infection.

Design: NK cell responses were evaluated by flow cytometry and ELISA following challenge with HBV antigens in HBV vaccinated, non-vaccinated and chronic HBV-infected individuals.

Results: NK cells from vaccinated subjects demonstrated higher cytotoxic and proliferative responses against autologous hepatitis B surface antigen (HBsAg)-pulsed monocyte-derived dendritic cells (moDCs) compared with unvaccinated subjects. Moreover, NK cell lysis of HBsAg-pulsed moDCs was significantly higher than that of hepatitis B core antigen (HBcAg)-pulsed moDCs (non-vaccine antigen) or tumour necrosis factor α-activated moDCs in a NKG2D-dependent manner. The mNKs response was mediated by CD56dim NK cells coexpressing CD57, CD69 and KLRG1. Further, mNKs from chronic hepatitis B patients exhibited greater degranulation against HBcAg-pulsed moDCs compared with unvaccinated or vaccinated patients. Notably, mNK activity was negatively correlated with HBV DNA levels.

Conclusions: Our data support the presence of a mature mNKs following HBV antigen exposure either through vaccination or infection. Harnessing these antigen specific, functionally active mNKs provides an opportunity to develop novel treatments targeting HBV in chronic infection.

Keywords: cellular immunity; chronic viral hepatitis; hepatitis B; immune response.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment in

Publication types